scholarly article | Q13442814 |
P356 | DOI | 10.1086/317934 |
P698 | PubMed publication ID | 11110649 |
P2093 | author name string | Jakobsen H | |
Jonsdottir I | |||
Saeland E | |||
Ingolfsdottir G | |||
Sigurdardottir ST | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | invasive infection | Q123987771 |
Streptococcus pneumoniae | Q221179 | ||
pneumococcal conjugate vaccine | Q7205991 | ||
P1104 | number of pages | 8 | |
P304 | page(s) | 253-260 | |
P577 | publication date | 2000-12-08 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B | |
P478 | volume | 183 |
Q37293669 | Animal models of Streptococcus pneumoniae disease |
Q33998997 | Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable? |
Q33593822 | Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection. |
Q50869969 | Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children. |
Q37598755 | Effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain |
Q35139987 | Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides |
Q35783918 | Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial |
Q41762311 | Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C. |
Q36227569 | Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria |
Q37130999 | Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees |
Q44029840 | Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model. |
Q34437804 | Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam |
Q35004648 | Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial |
Q79277933 | Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly |
Q34935287 | Pneumococcal Serotype 19F Conjugate Vaccine Induces Cross-Protective Immunity to Serotype 19A in a Murine Pneumococcal Pneumonia Model |
Q33973455 | Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study |
Q24245934 | Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age |
Q41195561 | Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. |
Q33792707 | Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice |
Q51798471 | Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance. |
Q33944443 | Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children |
Q74100868 | Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle |
Q35155427 | Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides |
Q40423092 | Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model |
Q34720274 | Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases |
Search more.